Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.

[1]  Y. Barenholz,et al.  Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. , 1999, Vaccine.

[2]  C. Guguen-Guillouzo,et al.  Infection Process of the Hepatitis B Virus Depends on the Presence of a Defined Sequence in the Pre-S1 Domain , 1999, Journal of Virology.

[3]  C. Guguen-Guillouzo,et al.  Role of the Pre-S2 Domain of the Large Envelope Protein in Hepatitis B Virus Assembly and Infectivity , 1998, Journal of Virology.

[4]  E. Muchmore,et al.  Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products. , 1998, Vaccine.

[5]  C. Partidos,et al.  Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. , 1997, Virology.

[6]  S. Mishiro,et al.  Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing. , 1994, Vaccine.

[7]  W. Gerlich,et al.  Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. , 1994, Vaccine.

[8]  S. Kuroda,et al.  Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. , 1992, The Journal of biological chemistry.

[9]  A. Neurath,et al.  Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. , 1991, Molecular immunology.

[10]  S. Kuroda,et al.  Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). , 1991, Vaccine.

[11]  A. Kakinuma,et al.  Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). , 1990, Vaccine.

[12]  A. Neurath,et al.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. , 1989, Vaccine.

[13]  Miyazaki Takeshi,et al.  Efficient expression of genetically engineered hepatitis B virus surface antigen P31 proteins in yeast. , 1989 .

[14]  Koichi Kato,et al.  Recombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: purification and characterization , 1988 .

[15]  E. Emini,et al.  A candidate vaccine for hepatitis B containing the complete viral surface protein , 1988, Hepatology.

[16]  K. Matsubara,et al.  Expression of hepatitis B virus middle and large surface antigen genes in Saccharomyces cerevisiae , 1987, Journal of virology.

[17]  D. Milich Immunological response to pre-S antigens of the hepatitis B virus. , 1987, Viral immunology.

[18]  S. Mishiro,et al.  A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. R. Neurath,et al.  Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus , 1986, Cell.

[20]  F. Chisari,et al.  Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. , 1986, Journal of immunology.

[21]  J T Yang,et al.  Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.

[22]  F. Chisari,et al.  Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Chisari,et al.  Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. , 1985, Science.

[24]  S. Kent,et al.  Hepatitis B virus contains pre-S gene-encoded domains , 1985, Nature.

[25]  Kikuchi Masakazu,et al.  Expression of hepatitis B virus surface antigen P31 gene in Escherichia coli. , 1985, Gene.

[26]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.

[27]  Y. Miyakawa,et al.  A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. , 1983, Gastroenterology.